Agilent Technologies Set to Report Earnings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Source: Yahoo Finance
- Earnings Preview: Agilent Technologies is set to report earnings this Wednesday after the bell, with market expectations for an 8% year-on-year revenue growth, an improvement from the 6% increase recorded in the same quarter last year, indicating the company's stability and growth potential in the market.
- Revenue Performance: Last quarter, Agilent reported revenues of $1.80 billion, up 7% year-on-year, and while the revenue guidance exceeded analysts' expectations, the actual revenue was in line with estimates, reflecting uncertainty in the company's revenue forecasting.
- Market Sentiment: Investor sentiment in the research tools and consumables sector has been positive, with average share prices rising 2.7% over the past month, whereas Agilent's stock has declined by 1.2%, indicating a cautious outlook on its future performance.
- Analyst Expectations: Most analysts have reaffirmed their estimates for Agilent over the past 30 days, with an average price target of $161.13 compared to the current share price of $114.96, suggesting a generally optimistic view on the company's future growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy A?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on A
Wall Street analysts forecast A stock price to rise
13 Analyst Rating
12 Buy
1 Hold
0 Sell
Strong Buy
Current: 115.840
Low
160.00
Averages
171.67
High
180.00
Current: 115.840
Low
160.00
Averages
171.67
High
180.00
About A
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
BofA Upgrades Agilent to Buy Amid Strong Growth
- Rating Upgrade: BofA Securities upgraded Agilent Technologies from hold to buy, citing the company's fiscal 2026 financial performance exceeding expectations, demonstrating strong growth and execution, with shares rising approximately 16% in Thursday morning trading.
- Price Target Adjustment: Although the price target was lowered from $150 to $145, it still indicates about 25% upside, reflecting analysts' optimistic outlook on the company's future performance, particularly supported by key growth drivers like liquid and gas chromatography.
- Solid Execution: Analyst Michael Ryskin noted that Agilent's execution in Q2 was robust, with few new negative surprises despite widespread fears of a slowdown in the chemicals sector, providing a solid foundation for continued growth.
- Reasonable Valuation: Ryskin emphasized that Agilent's valuation is reasonable, and given the myriad issues faced by other companies in the tools sector, it is becoming an increasingly attractive investment asset, with FY 2026 EPS forecasted to reach $6.00 to $6.10, driving an 85 basis point expansion in operating margins.
See More
US Stocks Under Pressure as Oil Prices Surge
- Market Pressure Intensifies: The S&P 500 index fell 0.14%, the Dow Jones Industrial Average dropped 0.27%, and the Nasdaq 100 index decreased 0.34% as crude oil prices surged over 2% following fresh US attacks on Iran, indicating heightened sensitivity to geopolitical risks.
- Economic Data Impact: The April core PCE price index rose 3.3% year-on-year, meeting expectations, but the unexpected 1.1% decline in April capital goods new orders signals potential economic slowdown, which may heighten investor concerns about future growth.
- Rising Unemployment Claims: Initial jobless claims in the US increased by 5,000 to 215,000, exceeding expectations of 211,000, reflecting a weakening labor market that could prompt the Fed to adopt a more cautious stance in future policy decisions.
- Earnings Season Insights: As of now, 83% of the 479 S&P 500 companies that reported earnings exceeded expectations, with Q1 earnings projected to rise 12% year-on-year; however, excluding the tech sector, growth is only expected at 3%, highlighting a divergence in overall profitability.
See More
Key Wall Street Ratings Updates for Thursday
- Tesla Robotaxi Expansion: Morgan Stanley reiterates Tesla as equal weight, noting survey checks indicate increased hiring of 'AI Safety Operators' in northern metro areas, suggesting Tesla is gearing up for robotaxi operations expansion, which could enhance future revenues.
- National Health Properties Outlook: Citizens initiates coverage of National Health Properties as outperform, believing the REIT is enhancing organic growth by increasing exposure to Senior Housing Operating Properties, indicating confidence in the senior living market.
- Nvidia Data Center Potential: Bernstein reiterates Nvidia as outperform, highlighting the enormous and still early datacenter opportunity, which is expected to provide significant upside, reflecting optimism in tech stocks.
- Quanta Services Rating Upgrade: Oppenheimer upgrades Quanta Services from perform to outperform with an $800 price target, indicating strong growth potential in the coming years, particularly in adjusted EBITDA expectations.
See More
Significant Stock Movements for Multiple Companies
- Dollar Tree Earnings Beat: Dollar Tree reported adjusted earnings of $1.74 per share for Q1, exceeding analyst expectations of $1.53, leading to an over 11% stock surge, while the partnership with DoorDash enhances its competitive edge through on-demand delivery.
- Salesforce Guidance Adjustment: Salesforce guided for current-quarter revenue between $11.27 billion and $11.35 billion, falling short of the $11.36 billion expected by analysts, resulting in a 1% stock decline; however, the raised full-year earnings guidance indicates confidence in future growth.
- Agilent Raises Earnings Outlook: Agilent Technologies increased its full-year adjusted earnings guidance to between $6 and $6.10 per share, surpassing previous estimates of $5.90 to $6.04, causing a 9% stock increase that reflects strong performance in the healthcare equipment sector.
- Snowflake Soars: Snowflake plans to invest $6 billion in Amazon Web Services over five years and reported Q1 adjusted earnings of $0.39 per share and revenue of $1.39 billion, both exceeding market expectations, resulting in a nearly 37% stock increase.
See More
Agilent Technologies Exceeds Q2 Earnings Expectations
- Significant Revenue Growth: Agilent Technologies reported $1.83 billion in revenue for Q2, reflecting a 6.3% year-over-year increase that surpassed market expectations, thereby reinforcing its leadership position in the scientific instruments market.
- Earnings Per Share Increase: The company achieved an earnings per share of $1.49, representing a 14% year-over-year growth, which highlights Agilent's success in cost control and operational efficiency, boosting investor confidence in future performance.
- Strategic Pricing Power: Agilent's strategic pricing capability delivered approximately 200 basis points of pricing improvement in Q2, coupled with the full mitigation of tariff impacts, which is expected to positively influence the company's profit margins and financial performance in the second half of the year.
- Optimistic Outlook: Agilent raised its FY 2026 core growth forecast to 4.5% to 6% and increased its EPS guidance to $6.00 to $6.10, reflecting management's confidence in future market demand, particularly in instrument replacement cycles and innovation-driven market share gains.
See More
Agilent Technologies Reports Strong Earnings, Exceeding Revenue Guidance
- Revenue Growth Exceeds Expectations: Agilent Technologies reported revenue of $1.83 billion with a core growth rate of 6.3%, surpassing guidance by 80 basis points, indicating strong performance in key markets, particularly in pharmaceuticals and chemical materials.
- Significant Margin Improvement: The company achieved an operating margin of 26.4%, up 130 basis points year-over-year, driven by the implementation of the Ignite operating system, which enhanced strategic pricing and operational efficiencies, thereby boosting overall profitability.
- Earnings Per Share Growth: EPS reached $1.49, reflecting a 14% year-over-year increase and exceeding guidance by $0.07, showcasing the company's competitive edge and ongoing improvement in profitability.
- Optimistic Future Outlook: The company provided full-year revenue guidance of $7.39 billion to $7.49 billion, with core growth projected at 4.5% to 6%, and raised EPS guidance to $6 to $6.10, demonstrating management's confidence in future growth prospects.
See More
BofA Upgrades Agilent to Buy Amid Strong Growth
- Rating Upgrade: BofA Securities upgraded Agilent Technologies from hold to buy, citing the company's fiscal 2026 financial performance exceeding expectations, demonstrating strong growth and execution, with shares rising approximately 16% in Thursday morning trading.
- Price Target Adjustment: Although the price target was lowered from $150 to $145, it still indicates about 25% upside, reflecting analysts' optimistic outlook on the company's future performance, particularly supported by key growth drivers like liquid and gas chromatography.
- Solid Execution: Analyst Michael Ryskin noted that Agilent's execution in Q2 was robust, with few new negative surprises despite widespread fears of a slowdown in the chemicals sector, providing a solid foundation for continued growth.
- Reasonable Valuation: Ryskin emphasized that Agilent's valuation is reasonable, and given the myriad issues faced by other companies in the tools sector, it is becoming an increasingly attractive investment asset, with FY 2026 EPS forecasted to reach $6.00 to $6.10, driving an 85 basis point expansion in operating margins.
See More
US Stocks Under Pressure as Oil Prices Surge
- Market Pressure Intensifies: The S&P 500 index fell 0.14%, the Dow Jones Industrial Average dropped 0.27%, and the Nasdaq 100 index decreased 0.34% as crude oil prices surged over 2% following fresh US attacks on Iran, indicating heightened sensitivity to geopolitical risks.
- Economic Data Impact: The April core PCE price index rose 3.3% year-on-year, meeting expectations, but the unexpected 1.1% decline in April capital goods new orders signals potential economic slowdown, which may heighten investor concerns about future growth.
- Rising Unemployment Claims: Initial jobless claims in the US increased by 5,000 to 215,000, exceeding expectations of 211,000, reflecting a weakening labor market that could prompt the Fed to adopt a more cautious stance in future policy decisions.
- Earnings Season Insights: As of now, 83% of the 479 S&P 500 companies that reported earnings exceeded expectations, with Q1 earnings projected to rise 12% year-on-year; however, excluding the tech sector, growth is only expected at 3%, highlighting a divergence in overall profitability.
See More
Key Wall Street Ratings Updates for Thursday
- Tesla Robotaxi Expansion: Morgan Stanley reiterates Tesla as equal weight, noting survey checks indicate increased hiring of 'AI Safety Operators' in northern metro areas, suggesting Tesla is gearing up for robotaxi operations expansion, which could enhance future revenues.
- National Health Properties Outlook: Citizens initiates coverage of National Health Properties as outperform, believing the REIT is enhancing organic growth by increasing exposure to Senior Housing Operating Properties, indicating confidence in the senior living market.
- Nvidia Data Center Potential: Bernstein reiterates Nvidia as outperform, highlighting the enormous and still early datacenter opportunity, which is expected to provide significant upside, reflecting optimism in tech stocks.
- Quanta Services Rating Upgrade: Oppenheimer upgrades Quanta Services from perform to outperform with an $800 price target, indicating strong growth potential in the coming years, particularly in adjusted EBITDA expectations.
See More
Significant Stock Movements for Multiple Companies
- Dollar Tree Earnings Beat: Dollar Tree reported adjusted earnings of $1.74 per share for Q1, exceeding analyst expectations of $1.53, leading to an over 11% stock surge, while the partnership with DoorDash enhances its competitive edge through on-demand delivery.
- Salesforce Guidance Adjustment: Salesforce guided for current-quarter revenue between $11.27 billion and $11.35 billion, falling short of the $11.36 billion expected by analysts, resulting in a 1% stock decline; however, the raised full-year earnings guidance indicates confidence in future growth.
- Agilent Raises Earnings Outlook: Agilent Technologies increased its full-year adjusted earnings guidance to between $6 and $6.10 per share, surpassing previous estimates of $5.90 to $6.04, causing a 9% stock increase that reflects strong performance in the healthcare equipment sector.
- Snowflake Soars: Snowflake plans to invest $6 billion in Amazon Web Services over five years and reported Q1 adjusted earnings of $0.39 per share and revenue of $1.39 billion, both exceeding market expectations, resulting in a nearly 37% stock increase.
See More
Agilent Technologies Exceeds Q2 Earnings Expectations
- Significant Revenue Growth: Agilent Technologies reported $1.83 billion in revenue for Q2, reflecting a 6.3% year-over-year increase that surpassed market expectations, thereby reinforcing its leadership position in the scientific instruments market.
- Earnings Per Share Increase: The company achieved an earnings per share of $1.49, representing a 14% year-over-year growth, which highlights Agilent's success in cost control and operational efficiency, boosting investor confidence in future performance.
- Strategic Pricing Power: Agilent's strategic pricing capability delivered approximately 200 basis points of pricing improvement in Q2, coupled with the full mitigation of tariff impacts, which is expected to positively influence the company's profit margins and financial performance in the second half of the year.
- Optimistic Outlook: Agilent raised its FY 2026 core growth forecast to 4.5% to 6% and increased its EPS guidance to $6.00 to $6.10, reflecting management's confidence in future market demand, particularly in instrument replacement cycles and innovation-driven market share gains.
See More
Agilent Technologies Reports Strong Earnings, Exceeding Revenue Guidance
- Revenue Growth Exceeds Expectations: Agilent Technologies reported revenue of $1.83 billion with a core growth rate of 6.3%, surpassing guidance by 80 basis points, indicating strong performance in key markets, particularly in pharmaceuticals and chemical materials.
- Significant Margin Improvement: The company achieved an operating margin of 26.4%, up 130 basis points year-over-year, driven by the implementation of the Ignite operating system, which enhanced strategic pricing and operational efficiencies, thereby boosting overall profitability.
- Earnings Per Share Growth: EPS reached $1.49, reflecting a 14% year-over-year increase and exceeding guidance by $0.07, showcasing the company's competitive edge and ongoing improvement in profitability.
- Optimistic Future Outlook: The company provided full-year revenue guidance of $7.39 billion to $7.49 billion, with core growth projected at 4.5% to 6%, and raised EPS guidance to $6 to $6.10, demonstrating management's confidence in future growth prospects.
See More
